Concepedia

Ö. Ataman

ÖA

14

Publications

613

Citations

13

H-Index

2001

Active since

Affiliations

Dokuz Eylül University(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

AstraZeneca (United Kingdom)

University of East Anglia

Ö. Ataman is an author at Dokuz Eylül University specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2001–2020

14

Publications

14

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non–Small-Cell Lung Cancer and Poor Performance Status

Glenwood Goss, David Ferry, Rafal Wierzbicki et al. · Journal of Clinical Oncology · 2009 · 116 citations · Full text

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors

David S. Boss, Petronella O. Witteveen, J. van der Sar et al. · Annals of Oncology · 2010 · 107 citations · Full text

Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors

Gary K. Schwartz, Richard D. Carvajal, Rachel Midgley et al. · Investigational New Drugs · 2012 · 77 citations

, , +9

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancers

David S. Hong, Aparna R. Parikh, Geoffrey I. Shapiro et al. · Journal for ImmunoTherapy of Cancer · 2020 · 69 citations · Full text

Improving the Capture of Adverse Event Data in Clinical Trials: The Role of the International Atomic Energy Agency

S.E. Davidson, Andy Trotti, Ö. Ataman et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 36 citations · Full text

, , +11

Rows per page

1–5 of 14